These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 9113940

  • 1. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.
    Simons FE, Gerstner TV, Cheang MS.
    Pediatrics; 1997 May; 99(5):655-9. PubMed ID: 9113940
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 3. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
    Giannini D, Bacci E, Dente FL, Di Franco A, Vagaggini B, Testi R, Paggiaro P.
    Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
    [Abstract] [Full Text] [Related]

  • 4. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 5. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ, Aziz I.
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [Abstract] [Full Text] [Related]

  • 6. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH, Kharitonov SA, Barnes PJ.
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 8. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.
    JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.
    Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM, Challenge-Rescue Study Group.
    Respir Med; 2004 Nov 11; 98(11):1051-62. PubMed ID: 15526805
    [Abstract] [Full Text] [Related]

  • 10. Prevention of exercise induced asthma by inhaled salmeterol xinafoate.
    Green CP, Price JF.
    Arch Dis Child; 1992 Aug 11; 67(8):1014-7. PubMed ID: 1355645
    [Abstract] [Full Text] [Related]

  • 11. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.
    Chest; 1999 Sep 11; 116(3):595-602. PubMed ID: 10492259
    [Abstract] [Full Text] [Related]

  • 12. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol.
    Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP.
    Respir Med; 1994 May 11; 88(5):363-8. PubMed ID: 7913549
    [Abstract] [Full Text] [Related]

  • 13. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
    Simons FE.
    N Engl J Med; 1997 Dec 04; 337(23):1659-65. PubMed ID: 9385125
    [Abstract] [Full Text] [Related]

  • 14. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T.
    Ann Allergy Asthma Immunol; 1999 Feb 04; 82(2):205-11. PubMed ID: 10071526
    [Abstract] [Full Text] [Related]

  • 15. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
    Richter K, Janicki S, Jörres RA, Magnussen H.
    Eur Respir J; 2002 May 04; 19(5):865-71. PubMed ID: 12030726
    [Abstract] [Full Text] [Related]

  • 16. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction.
    Boulet LP, Turcotte H, Cartier A, Milot J, Côté J, Malo JL, Laviolette M.
    Chest; 1998 Aug 04; 114(2):373-9. PubMed ID: 9726717
    [Abstract] [Full Text] [Related]

  • 17. Overnight protection by inhaled salmeterol on exercise-induced asthma in children.
    Carlsen KH, Røksund O, Olsholt K, Njå F, Leegaard J, Bratten G.
    Eur Respir J; 1995 Nov 04; 8(11):1852-5. PubMed ID: 8620951
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I, Hall IP, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Mar 04; 101(3):337-41. PubMed ID: 9525449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.